Authors:
Black, DM
Thompson, DE
Bauer, DC
Ensrud, K
Musliner, T
Hochberg, MC
Nevitt, MC
Suryawanshi, S
Cummings, SR
Citation: Dm. Black et al., Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial (vol 85, pg 4118, 2000), J CLIN END, 86(2), 2001, pp. 938-938
Citation: De. Thompson et al., Two-dimensional ultrafast infrared vibrational echo studies of solute-solvent interactions and dynamics, J CHEM PHYS, 115(1), 2001, pp. 317-330
Citation: De. Thompson et al., Solute-solvent interactions: two-dimensional ultrafast infrared vibrational echo experiments, CHEM P LETT, 340(3-4), 2001, pp. 267-274
Citation: De. Thompson et Jc. Wright, Model for spectral artifacts in two-dimensional four-wave mixing spectra from absorption and refractive index dispersion at infrared resonances, J PHYS CH A, 104(48), 2000, pp. 11282-11289
Authors:
Schnitzer, T
Bone, HG
Crepaldi, G
Adami, S
McClung, M
Kiel, D
Felsenberg, D
Recker, RR
Tonino, RP
Roux, C
Pinchera, A
Foldes, AJ
Greenspan, SL
Levine, MA
Emkey, R
Santora, AC
Kaur, A
Thompson, DE
Yates, J
Orloff, JJ
Citation: T. Schnitzer et al., Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis, AGING-CLIN, 12(1), 2000, pp. 1-12
Authors:
Vogt, TM
Ross, PD
Palermo, L
Musliner, T
Genant, HK
Black, D
Thompson, DE
Citation: Tm. Vogt et al., Vertebral fracture prevalence among women screened for the fracture intervention trial and a simple clinical tool to screen for undiagnosed vertebralfractures, MAYO CLIN P, 75(9), 2000, pp. 888-896
Authors:
Zhao, W
Murdoch, KM
Condon, NJ
Besemann, DM
Meyer, KA
Chen, PC
Hamilton, JP
Zilian, A
Labuda, MJ
Thompson, DE
Carlson, RJ
Hurst, GB
Riebe, MT
Steehler, JK
Wright, JC
Citation: W. Zhao et al., Comparisons between 2D doubly vibrationally enhanced four wave mixing and site selective spectroscopy, J LUMINESC, 87-9, 2000, pp. 90-95
Authors:
Black, DM
Thompson, DE
Bauer, DC
Ensrud, K
Musliner, T
Hochberg, MC
Nevitt, MC
Suryawanshi, S
Cummings, SR
Citation: Dm. Black et al., Fracture risk reduction with alendronate in women with osteoporosis: The Fracture Intervention Trial, J CLIN END, 85(11), 2000, pp. 4118-4124
Citation: Ks. Lyness et De. Thompson, Climbing the corporate ladder: Do female and male executives follow the same route?, J APPL PSYC, 85(1), 2000, pp. 86-101
Authors:
Nevitt, MC
Thompson, DE
Black, DM
Rubin, SR
Ensrud, K
Yates, AJ
Cummings, SR
Citation: Mc. Nevitt et al., Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures, ARCH IN MED, 160(1), 2000, pp. 77-85
Authors:
Murdoch, KM
Thompson, DE
Meyer, KA
Wright, JC
Citation: Km. Murdoch et al., Modeling window contributions to four-wave mixing spectra and measurementsof third-order optical susceptibilities, APPL SPECTR, 54(10), 2000, pp. 1495-1505
Authors:
Ensrud, KE
Thompson, DE
Cauley, JA
Nevitt, MC
Kado, DM
Hochberg, MC
Santora, AC
Black, DM
Citation: Ke. Ensrud et al., Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass, J AM GER SO, 48(3), 2000, pp. 241-249
Authors:
Nevitt, MC
Ross, PD
Palermo, L
Musliner, T
Genant, HK
Thompson, DE
Citation: Mc. Nevitt et al., Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: Effect of number and spinal location of fractures, BONE, 25(5), 1999, pp. 613-619
Citation: Dm. Black et De. Thompson, The effect of alendronate therapy on osteoporotic fracture in the vertebral fracture arm of the Fracture Intervention Trial, INT J CL PR, 1999, pp. 46-50
Authors:
Loge, FJ
Emerick, RW
Thompson, DE
Nelson, DC
Darby, JL
Citation: Fj. Loge et al., Factors influencing ultraviolet disinfection performance part I: Light penetration to wastewater particles, WAT ENV RES, 71(3), 1999, pp. 377-381
Authors:
Loge, FJ
Emerick, RW
Thompson, DE
Nelson, DC
Darby, JL
Citation: Fj. Loge et al., Development of a fluorescent 16S rRNA oligonucleotide probe specific to the family Enterobacteriaceae, WAT ENV RES, 71(1), 1999, pp. 75-83
Authors:
Wasnich, RD
Ross, PD
Thompson, DE
Cizza, G
Yates, AJ
Citation: Rd. Wasnich et al., Skeletal benefits of two years of alendronate treatment are similar for early postmenopausal Asian and Caucasian women, OSTEOPOR IN, 9(5), 1999, pp. 455-460
Citation: P. Mitchell et al., Children's understanding that utterances emanate from minds: using speakerbelief to aid interpretation, COGNITION, 72(1), 1999, pp. 45-66
Authors:
Cummings, SR
Black, DM
Thompson, DE
Applegate, WB
Barrett-Connor, E
Musliner, TA
Palermo, L
Prineas, R
Rubin, SM
Scott, JC
Vogt, T
Wallace, R
Yates, AJ
LaCroix, AZ
Citation: Sr. Cummings et al., Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial, J AM MED A, 280(24), 1998, pp. 2077-2082